chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in the shot spot and a migraine same day about an hour  then she took Tylenol and the headache went away after 45 minutes
lower extremity weakness, numbness, and fasciculations-started one month after second dose  treating with acupuncture-are improving
pain in the feet, going from one to the other and also moving to their back and arm; Pain in feet, painful going from one to the other and also moving to their back and arm; pain in the feet, going from one to the other and also moving to their back and arm; feel their limbs are asleep; difficult for them to go down or up the stairs because they cannot bend their feet; a limp on the right foot; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in the feet, going from one to the other and also moving to their back and arm), PAIN IN EXTREMITY (Pain in feet, painful going from one to the other and also moving to their back and arm), PAIN (pain in the feet, going from one to the other and also moving to their back and arm), LIMB DISCOMFORT (feel their limbs are asleep) and MOBILITY DECREASED (difficult for them to go down or up the stairs because they cannot bend their feet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in the feet, going from one to the other and also moving to their back and arm), PAIN IN EXTREMITY (Pain in feet, painful going from one to the other and also moving to their back and arm), PAIN (pain in the feet, going from one to the other and also moving to their back and arm), LIMB DISCOMFORT (feel their limbs are asleep), MOBILITY DECREASED (difficult for them to go down or up the stairs because they cannot bend their feet) and GAIT DISTURBANCE (a limp on the right foot). At the time of the report, BACK PAIN (pain in the feet, going from one to the other and also moving to their back and arm), PAIN IN EXTREMITY (Pain in feet, painful going from one to the other and also moving to their back and arm), PAIN (pain in the feet, going from one to the other and also moving to their back and arm), LIMB DISCOMFORT (feel their limbs are asleep), MOBILITY DECREASED (difficult for them to go down or up the stairs because they cannot bend their feet) and GAIT DISTURBANCE (a limp on the right foot) outcome was unknown.            No concomitant medications information was reported. No treatment medications were provided.
Nausea; Diarrhea; problems with taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, administration date: 04Feb2021, for COVID-19 immunisation. The following information was reported: DYSGEUSIA (non-serious) with onset 08Mar2021, outcome "unknown", described as "problems with taste"; NAUSEA (non-serious) with onset 09Mar2021, outcome "unknown", described as "Nausea"; DIARRHOEA (non-serious) with onset 09Mar2021, outcome "unknown", described as "Diarrhea". Additional Information: Events were described as follows: The patient had some problems with taste starting "last night". He had nausea this morning and diarrhea all day long. The patient was querying on how long the events will last or should he be taking something like Imodium. It was reported that the last one (COVID-19 vaccine) that he got was the one he was having problems with.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on front side above her stomach towards left side, after receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on front side above her stomach towards left side, after receiving second dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 012M20A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included LANSOPRAZOLE and ATORVASTATIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 09-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash on front side above her stomach towards left side, after receiving second dose). On 30-Apr-2021, RASH (Rash on front side above her stomach towards left side, after receiving second dose) had resolved. Not Provided          Treatment information was not provided.  Action taken with the mRNA-1273 in response to the event is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Additional information received, Updated the outcome of the event updated as recovered. On 25-Jun-2021: No new information
11/19/2018 A.M.: Nausea/vomitting; low grade fever 100F; chills.
On 11/01/06 I worked all day at School. I did not have a cold or any other infection that I know of. At 3pm I received a flu shot at the school. At 6:30pm, I was sitting in church and began to feel like there was a lump in my throat. It was moderately difficult to swallow, but my breathing was normal. When I got home, starting at 7:40 pm I noticed that my voice was hoarse, It became more so, each hour. My jaw and throat were painful, they ached. I took 2 Ibuprofen (200mg each), and 1 antihistamine. At first I thought I was coming down with a cold, and this is the routine I use for a cold. I took the same amount of medicine at 12:30 am and 6am. At 6am my throat was fine, could swallow ok, but both eyes were reddened, sclera beet red and both eyelids reddened and itchy. I stayed home and continued to take Ibuprofen and antihistamine as noted. By evening Thursday, 11/2, most of the eye redness was gone, jaw pain was gone. I wrote these notes on Thursday evening 11/02. Resumed usual schedule on Friday.
Severe tenderness, aching and swelling in the left arm pit. Feels like fluid is within the armpit.
G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 WEAKNESS OF BILAT LEGS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 WEAKNESS OF BILAT LEGS G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 CHRONIC AUTOIMMUNE HEPATITIS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 CHRONIC AUTOIMMUNE HEPATITIS G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 CHRONIC VIRAL HEPATITIS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 CHRONIC VIRAL HEPATITIS G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 WEAKNESS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 WEAKNESS G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 ATRIAL FIBRILLATION, PAROXYSMAL J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 ATRIAL FIBRILLATION, PAROXYSMAL G40.909 EPILEPSY, UNSPECIFIED 3/16/2022 ATRIAL FIBRILLATION, PAROXYSMAL J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/5/2023 ATRIAL FIBRILLATION, PAROXYSMAL
Small pruritic patch on left inner thigh initially, then diffuse rash over next few days, especially on posterior aspect of bilateral axillae and inner thighs.  Primary vaccine site healing well.  No systemic sxs reported.  Not toxic looking.  Diagnosed with generalized vaccinia (mild) and treated with supportive care:  Hydroxizine 25-50mg qid prn for pruritis and Zantac 150mg bid prn.  Pt to follow-up in 24 hours for recheck.  Educated on Erythema Multiforme.
This spontaneous report as received from a healthcare worker (Medical Assistant) refers to an unspecified number of patients (age and gender unknown). The healthcare worker stated that improperly stored PEDVAXHIB (administration/dosage details unspecified) had been possibly administered to these patients between 17-DEC-2014 and 05-JAN-2015. Concomitant medications were not provided. This is one of several reports received from the same reporter. Additional information has been requested.
pale; sweating; felt weak; chills; headache; felt like throwing up but she didn't; got vaccine on her right arm and started having a sore arm that same day; This spontaneous case was reported by a consumer and describes the occurrence of PALLOR (pale), HYPERHIDROSIS (sweating), ASTHENIA (felt weak), VACCINATION SITE PAIN (got vaccine on her right arm and started having a sore arm that same day) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included TOCILIZUMAB (ACTEMRA) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (got vaccine on her right arm and started having a sore arm that same day). On 12-Feb-2021, the patient experienced PALLOR (pale), HYPERHIDROSIS (sweating), ASTHENIA (felt weak), CHILLS (chills), HEADACHE (headache) and NAUSEA (felt like throwing up but she didn't). On 13-Feb-2021, PALLOR (pale), HYPERHIDROSIS (sweating), ASTHENIA (felt weak), CHILLS (chills), HEADACHE (headache) and NAUSEA (felt like throwing up but she didn't) had resolved. At the time of the report, VACCINATION SITE PAIN (got vaccine on her right arm and started having a sore arm that same day) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Non significant follow up
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown demographics. The patients medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored ROTATEQ orally (lot # and dose were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This RN was asked by clinic MA to administer a Moderna covid booster to patient above following a preventive visit. RN received consent from family, administered age appropriate and correct dose Moderna product after verifying with the CDC website ("Any COVID-19 vaccine product (age appropriate) may be administered for a booster dose. It does not need to be the same product used for the primary series.") RN administered Moderna Child, 0.5mL and pt tolerated well. RN discovered following the patient's exit from the clinic that the Moderna product is not approved for boosters for this age group and that the patient should have received Pfizer. RN notified manager of this occurence.  Manager notified family of error in administration. Pt not having any adverse reaction to the vaccine at this time.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 70-year-old female patient who received SHINGRIX (batch number P3777, expiry date 30th January 2020). On 3rd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 18th May 2018, 15 days after receiving SHINGRIX, the patient experienced shingles (serious criteria other: as per reporter). The patient was treated with antivirals for systemic use. On an unknown date, the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The patient received the vaccine on the left arm. The healthcare professional (HCP) stated that the patient was diagnosed with shingles on 18th May 2018. The HCP stated that the patient presented to the retail pharmacy to have prescriptions filled for PO (per os) and topical antivirals after seeking medical treatment on 18th May 2018. The HCP was unsure when exactly the patient's symptoms were started. The HCP was willing to provide further details regarding this adverse event after she speaks with patient again later on the reporting day. The HCP was opened to be contacted from the safety department for further details. The HCP stated that she/he had no idea when asked about clinical opinion on causality.
feeling weird; feeling sick; . This case was reported by a consumer via call center representative and described the occurrence of weird feeling in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced weird feeling and feeling unwell. On an unknown date, the outcome of the weird feeling and feeling unwell were unknown.   It was unknown if the reporter considered the weird feeling and feeling unwell to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received the first dose and few days after receiving the vaccine, she remember feeling weird and feeling sick.  The patient did not remember what reaction she had.  She discussed this incident with her physician and the physician recommended that she would not take the second dose. No additional information was provided.  The reporter did not consent to followup
reduced attention to details, diminished alertness, being cloudy headed, and clouded headedness; he noticed his "mental acuity [was] reduced; reduced attention to details, diminished alertness, being cloudy headed, and clouded headedness; He said he also has "drowsiness" which is getting more significant; cut his thumb while chopping asparagus He added he bled terribly, therefore he grabbed a clean paper towel, stanched the bleeding, and had to "seal" the wound with all the white first aid tape he had.; ut his thumb while chopping asparagus He added he bled terribly; This is a spontaneous report from a contactable consumer reporting for himself.   A 70-years-old male patient received  second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 15Mar2021 (Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The consumer after the second vaccine doses noticed his "mental acuity [was] reduced". He also described/referred to it as: "reduced attention to details, diminished alertness, being cloudy headed, and clouded headedness". After the second dose, this experience was "worst, more significant and continues to get more significant".  He explained he drives a large tracker truck for (Company name) and had to take days off work due to his symptoms. He specified the following details post-vaccination with his second dose: Monday night, he was preparing diner around 8 pm and cut his thumb while chopping asparagus. He added he bled terribly, therefore he grabbed a clean paper towel, stanched the bleeding, and had to "seal" the wound with all the white first aid tape he had. He then said he called his physician on Tuesday who returned his call around 5:30 that same day, and who recommended to go to the ER since stiches were needed. He added he resisted to go to the ER because of his symptoms affecting his driving but went upon his HCP's encouragement. He explained once at the ER, the doctor there said he wouldn't recommend stiches since this may seal in the bacteria from the improper dressing he had, which will affect the make the healing period and scaring.  He added they cleaned and sealed his wound nicely then they offered a tetanus shot, which he got. He described his thumb as a "flap finger". He explained when driving back home he almost had an accident due to not paying attention to details, which he wouldn't have done in his 40 years of driving experience. He said he also has "drowsiness" which is getting more significant. Events outcome was unknown.  Information about lot/batch has been requested.
Within 48 hours of receiving 2nd Moderna vaccine , developed red  area  hot to touch and swollen , just below injection site , on left upper arm.   By morn , involved area had extended.  Seen by MD, prescribed Keflex for 7 days for cellulitis.
Intense Muscle Aches and Weakness Intense Joint Pain Fever Chills with sweating Small rash and intense itching in left arm Headache that made me nauseous
complained of feeling nauseous few minutes after immunization given.  Rested for about 10 minutes and drank some water than felt better and left clinic with family.
Appearance of hives/rash several times per week that last for 15 minutes to an hour at a time and appear on seemingly random areas of the body. Possibly triggered by pressure as it is often noticed after pressure is placed on an area.  Affected skin area becomes raised, pink, and itchy. This is most commonly occurring on arms but does appear on other areas. This is not something that had ever occurred prior to vaccination.
VISION BLURRY OUT IN SUN/VISION PROBLEMS; HEADACHE OVER RIGHT EYE AND MOVES TO BACK OF HEAD/  HEADACHE IS WORSENING; ARM WAS SORE; This spontaneous report received from a patient concerned a 53 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: bad nerves, high cholesterol, non-alcohol user, non-smoker, and bad back, and other pre-existing medical conditions included: Patient did not have known drug allergies and drug abuse or illicit drug usage. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 21-AUG-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 22-AUG-2021, the patient experienced arm was sore. On 28-AUG-2021, the patient experienced vision blurry out in sun/vision problems. On 28-AUG-2021, the patient experienced headache over right eye and moves to back of head/ headache is worsening. Laboratory data included: Pain scale (NR: not provided) 7 out of 10 (10 being the worst). Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine was not applicable. The patient recovered from arm was sore on 23-AUG-2021, and had not recovered from headache over right eye and moves to back of head/ headache is worsening, and vision blurry out in sun/vision problems. This report was non-serious. This case, from the same reporter is linked to 20210931789.
mild symptoms; exposed 10 days ago; This spontaneous case was reported by an other health care professional and describes the occurrence of GENERAL SYMPTOM (mild symptoms) and EXPOSURE TO COMMUNICABLE DISEASE (exposed 10 days ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced GENERAL SYMPTOM (mild symptoms) and EXPOSURE TO COMMUNICABLE DISEASE (exposed 10 days ago). At the time of the report, GENERAL SYMPTOM (mild symptoms) and EXPOSURE TO COMMUNICABLE DISEASE (exposed 10 days ago) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jan-2022, Laboratory test: positive (Positive) tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was exposed 10 days ago and had mild symptoms 7 days ago which were almost gone.  The patient enquired about receiving the booster dose.  No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Extreme itching all over, head ache, muscle/bone pains, stayed in bed 2 1/2 days, as each day past the pt got a little better. Hives on right arm, major pain at sight of injection, when pressing it turns yellow, blue and raised.
Redness, swelling. Tx - Tylenol/Motrin for pain. Presc for Keflex if worse.
Rapid heart rate above 100 beats per minute when normal is around 70. Hard to take a deep breath due to chest tightness. Started a few hours after vaccine and continued for over a week (still occurring today)
in days immediately following vaccine, patient reports mild headache, mild pharyngitis, and myalgias. these symptoms resolved with no symptoms for several days, followed by onset of urticarial 9-10 following vaccination. urticarial lesions lasted for 5d, on the 5th day, he had facial angioedema in association with urticaria, prompting ED visit. the patient continues to have urticaria on 24October19.
An hour after taking the vaccine the patient felt faint He went and laid down when he woke up he still felt the same way. He fell and hit his shoulder. He has lost all his energy.
Report received from a nurse (also the mother of the patient) on 12-Jan-2010. A 34 year-old female patient received the H1N1 vaccine (batch number unknown) on 01-Oct-2009. The patient's medical history and concomitant medications are unknown. On an unknown date, the patient developed arm soreness at the injection site. On 23-Nov-2009, 7 weeks and 4 days after administration of suspect drug, the patient was diagnosed with oral cancer. The patient also indicated she experienced nothing else out of the ordinary. Treatment details and event outcome are unknown. The patient stated she was not pregnant at the time of vaccination. Further information has been requested. The case was reported as serious because of medical significance. The company considered events to be unassessable in relation to the suspect drug because medical history is unknown.
redness, swelling, pain at sight, hurts to walk, scattered hives from knee to groin area
Mother stated after receiving immunizations on 12/28/06 she started noticing the pts. right arm swelling that approx. sometime during the evening/night.  She had been giving Motrin for preventative fever measures and then applied cold packs to the area when noticed the swelling but it continued to swell and started radiating down to pts. elbow and noticed a blister.  She took the pt. to the ED on 12/29/06 and they treated the pt. with septra and benadryl.  The patient followed up on 01/02/07. The area where the blister occurred was approx. 1 1/2 inches below the IM deltoid site of injection.  The swelling in the arm was decreased to almost normal size.
"COVID Arm" - approx 6 inch diameter hard, itchy, sore, red spot around the injection that started about a week after the first dose. It's been 3 days and it's still red and itchy, though it does seem to be getting marginally better.
This spontaneous report as received from a nurse refers to multiple patients with unknown ages and genders. On unknown dates the multiple patients were vaccinated with (Oka/Merck) VARIVAX (lot # J008229, expiration date: 12-JUL-2015, 0.5 ml, subcutaneous) which involved in a supported temperature excursion. No adverse effects noted by any patients. It was not specified if the multiple patients sought for medical attention. Additional information has been requested.